Monday, April 3, 2017 - 18:02

Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) today announces that the French version of its 2016 Reference document was filed with the Autorités des Marchés Financiers (AMF), the French stock-market authorities, on March 31st, 2017, under number D.17‑0282.

The 2016 Reference document is available on the Company’s website (section Investors/Regulated information and publications/Financial reports). Hard copies are available upon request to the investor relations department of the Company.

The Registration document notably includes the following information:

  • The 2016 annual financial report;
  • The report by the Chairman on the conditions for preparation and organization of the work of the Supervisory Board as well as on internal control;
  • The information relating to the Statutory Auditors’ fees.

The English version of the 2016 Reference document will be made available on Innate Pharma’s website during April 2017.

PR in English75.53 KB
CP en Français76.13 KB